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Summary 
We have used mtmvitus-mediated gene transfer to dent- 
onstrate compiementation of the cystic fibrosis (CF) 
defect In vitro. Amphotropic mtroviruses were used to 
transduce a functional cystic fibrosis transmembrane 
conductance regulator (CFTR) cDNA into CFPAC-1, a 
pancreatic adenocarcinoma ceil line derived from a 
patient with CF that stably expresses the chloride tram+ 
port abnormalities characteristic of CF. CFPAC-1 ceils 
were exposed to control virus (PLJ) and CFTR-exptess- 
ing virus (PLJ-CFTR); viral-transduced clones were 
isolated and subjected to molecular and physiologic 
analysis. RNA analysis detected a viral-derived CFTR 
transcript in ail of the PLJ-CFTR clones that contained 
unmarranged provirai sequences. Agents that increase 
intracellular cAMP stimulated l*R efflux in PLJ-CFTR 
clones but not PLJ clones. Whole-ceil patch-clamp 
performed on three responding clones showed that 
the anion effiux responses were due to cAMP stimula- 
tion of Cl conductance. Our findings indicate that ex- 
pression of the normal CFTR gene confers cAMPde- 
pendent Cl channel regulation on CF epitheliai ceils. 
introduction 
Cystic fibrosis (CF) is an autosomal recessive disorder 
characterized by abnormalities in water and electrolyte 
transport that lead to pancreatic and pulmonary insuffi- 
ciency (Taussig, 1964). Recent progress in our under- 
standing of the genetic and functional basis of CF has 
provided a foundation for better defining its molecular 
pathology as well as developing novel therapies based on 
somatic gene transfer. 
Functional expression of the CF defect reduces the 
chloride ion permeability of epithelial tissues (Quinton, 
1990). The ability of epitheliai ceils in the airways, sweat 
glands, pancreas, and other tissues to secrete Cl in re- 
sponse to CAMP-mediated agonists is lost or severely re- 
duced. Activation of apical membrane Cl channels by 
CAMP-dependent protein kinase is impaired, but chan- 
nels with normal conductance properties can be activated 
by other means, including agonists whose effects are 
mediated by increased cell Ca (Frizzell, 1987; Welsh, 
1990). These findings have led to the suggestion that the 
Cl channel per se is not defective in CF, but that the defect 
may lie in a regulatory protein that transduces the effects 
of protein kinase activation. Abnormalities in epitheliai so- 
dium transport in CF ceils (Boucher et al., 1986) support 
the concept of a regulatory defect that can affect other cel- 
lular functions. 
Isolation of the gene for CF (Rommens et al., 1989; Rior- 
dan et al., 1989; Kerem et al., 1989) has provided further 
insight into the molecular basis of the disease. The gene 
responsible for CF was localized to 250,000 bp of genomic 
DNA based on its location within the genome. it encodes 
a protein of 1,480 amino acids called the cystic fibrosis 
transmembrane conductance regulator (CFTR) (Riordan 
et al., 1989). The most compelling evidence thus far to 
support the role of CFTR in the etiology of CF has been 
provided by genetic analyses (Kerem et al., 1989). Se- 
quence analysis of the CFTR gene of CF chromosomes 
has revealed a variety of mutations (Cutting et al., 1990; 
White et al., 1990; Dean et al., 1990; Kerem et al., 1990). 
Extensive population studies have indicated that the most 
common CF mutation, a deletion of the 3 nucleotides that 
encode phenyialanine 508 (AF&, is present on 70% of 
all CF chromosomes, but never on normal chromosomes 
(Kerem et al., 1989; Cystic Fibrosis Genetic Analysis Con- 
sortium, 1990). 
The specific role that CFTR plays in Cl transport re- 
mains unclear. The CFTR protein contains several in- 
teresting functional domains including two nucleotide 
binding folds, a regulatory region that has many possible 
sites for phosphorylation, and two hydrophobic regions 
that probably interact with cell membranes. CFTR shows 
structural similarity with several members of the “ATP 
binding cassette” (ABC) superfamily of proteins, including 
the periplasmic binding proteins of prokaryotes and the 
P glycoprotein associated with multidrug resistance in 
higher eukaryotes (Riordan et al., 1989; Hyde et al., 1990). 
As the next step in understanding the role of CFTR in 
the dysreguiation of Cl channel activation in CF, we have 
achieved complementation of the CF defect in vitro by 




Early attempts to reconstitute a full-length CFTR cDNA 
from overlapping clones were uniformly unsuccessful. 
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Figure 1. Analysis of Proviral Sequences in Transduced CFPAC-1 Clones 
(A) Retroviral vector PW-CFTR. Important structural components of the vector include the LTR sequences, CFTR cDNA, sequences from the origin 
of SV40, the gene that confers resistance to G413 (Neo), and the origin of replication for pBR322 (PER). Sites of transcriptional initiation are indicated 
with arrows at the 5’LTR and internal SV40 sequences. Recognition sites for restriction endonucleases Kpnl and Hindlll are indicated. Probes specific 
for the CFTR gene (exon 13) and the Neo gene that were used in DNA and RNA blot analysis are indicated below the vector. 
(B) CFPAC-1 cells were infected with PLJ or PLJ-CFTR virus and selected in the presence of G413 in order to isolate individual clones. High molecular 
weight DNA was isolated from each clone and analyzed by gel blot hybridization. In the top panel, DNA was digested with Kpnl and the filter was 
hybridized to a Neo-specific probe; in the bottom panel, DNA was digested with Hindlll and the filter was hybridized to the exon 13 CFTR-specific 
probe. The 4.3 kb band in all lanes arises from the endogenous CFTR gene. Samples include: lane CFPAC-1, CFPAC-1 DNA (10 ug); lane 1 Copy, 
CFPAC-1 DNA (10 ug) supplemented with 7.5 pg of PWCFTR plasmid DNA; and lanes numbered l-10, DNA (10 ug) from PW-CFTR clones 1 through 
IO. The viral band comigrates with the endogenous band in clone 5; a unique integrant was clearly demonstrated in this clone when the filter was 
stripped and rehybridized with a Neo probe. Molecular size standards in kilobases are indicated at left. 
The exact cause of these difficulties remains to be de- 
fined, but we have data to show that prokaryotic transcrip- 
tion from internal CFTR cDNA sequences may result in 
the expression of a protein that is toxic to bacteria. The in- 
troduction of three silent mutations (T to C at 930, A to G 
at 933, and T to C at 936) into a restriction fragment of 
CFTR that spans exon 6b completely ablated this toxic ef- 
fect, potentially by interfering with the cryptic prokaryotic 
promoter, and enabled the reconstruction of 4.6 kb of con- 
tiguous CFTR cDNA sequence. The nucleotide sequence 
of this reconstructed cDNA was redetermined and found 
identical to that published previously (Riordan et al., 
1989) with the exception of the three silent mutations 
noted above. 
The modified CFTR cDNA was cloned into the previ- 
ously described retroviral vector PW (Korman etal., 1987). 
The proviral component of this recombinant vector, called 
PW-CFTR, is depicted in Figure 1A. Transcription from the 
5’ long terminal repeat (LTR) produces an 8.5 kb genomic 
transcript that is responsible for viral passage and CFTR 
expression. Transcription from SV40 sequences located 
internal to the LTRs leads to the formation of a second 
transcriptional unit that expresses a Neo selectable 
marker. 
Transfection of PW and PW-CFTR vectors into the virus 
packaging cell line VCrip led to the transient production 
of replication-defective virus. Limiting dilutions of virus 
stocks were used to infect CFPAC-1 cells, which were sub- 
sequently cultured in the presence of G418 in order to se- 
lect for transduced clones. Transiently produced PW- 
CFTR virus stocks had a lower titer (50 to lOO-fold) than 
those produced with the PW vector. Ten individual clones 
of cells were isolated from infections performed with each 
type of virus (named PW clones 1 through 10 and PW- 
CFTR clones 1 through 10) and subjected to molecular 
and physiologic analyses. 
IVansduced Clones Express Retmviral 
CFTR Sequences 
Retrovirally transduced clones of CFPAC-1 cells were ana- 
lyzed for proviral sequences as described for other cell 
types (Wilson et al., 1988,1990a, 1990b). Digestion of high 
molecular weight DNA with a restriction enzyme, Kpnl, 
that has unique sites in the vector LTRs releases all in- 
tegrated forms of the PW-CFTR provirus as a common 8.5 
kb fragment. Gel blot hybridization of Kpnl-restricted DNA 
revealed unrearranged proviral sequences with the ex- 
pected abundance of 1 copy per cell in lO/lO PW clones 
and 900 PW-CFTR clones (Figure lB, top panel). Hybrid- 
ization of the filter with a Neo-specific probe detected a 
markedly rearranged provirus in PW-CFTR clone 2; this 
virus apparently deleted a major part of the CFTR cDNA 
(data not shown). Gel blot hybridization analysis was also 
used to study the complexity and uniqueness of each 
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Figure 2. RNA Blot Analysis of CFPAC-1 Clones 
Clones of retrovirus-transduced CFPAC-1 cells were isolated and ana- 
lyzed for the presence of CFTR transcripts. Total cellular RNA was har- 
vested from individual clones and subjected to RNA blot analysis using 
the exon 13 CFTR probe to hybridize with the filter (top panel). The filter 
was stripped and rehybridized with a probe derived from human y-actin 
cDNA (bottom panel) to control for variation in sample loading. RNA 
samples (10 kg) were derived from the following cells: lanes T64, dupli- 
cate samples from the colonic tumor cell line T64; lane CFPAC-1, non- 
transduced CFPAC-1 cells; lane PW 6, CFPAC-1 clone 6 from the PW 
infection; and lanes numbered l-10, CFPAC-1 clones 1 through 10 
from the PW-CFTR infection. Molecular size markers in kilobases are 
noted at left. 
putative PW-CFTR clone. High molecular weight DNA 
was digested with Hindlll, a restriction enzyme with two 
internal sites in PW-CFTR, and analyzed with the exon 13 
CFTR-specific probe (Figure 18, bottom panel). This anal- 
ysis demonstrated the existence of a single, unique in- 
tegration site in 9/10 PW-CFTR clones; the CFTR-specific 
probe failed to detect the provirus in DNA from PW-CFTR 
clone 2 because of the apparent deletion described 
above. 
Expression of the retrovirally transduced CFTR gene 
was studied by RNA blot analysis using the CFTR exon 
13 probe (Figure 2). Total cellular RNA from the previously 
described human colon tumor cell line, T84, demonstrated 
high levels of the endogenous CFTR transcript. No CFTR 
transcript was detected by Northern analysis in mock- 
infected CFPAC-1 cells or PW clone 6, though CFTR RNA 
can be detected in CFPAC-1 by RNA-PCR. A viral-directed 
CFTR transcript of the expected size (i.e., 8.5 kb) was de- 
tected in 9/10 PW-CFTR clones; the CFTR probe failed to 
detect a transcript in RNA from the clone that contains the 
deleted provirus (PW-CFTR clone 2). 
Transduced Clones Show Forskolin Stimulation of 
Anion Transport 
shows the time course of the 1251 efflux rate constant (r) in 
two clones, PW 6 and PW-CFTR 6, with and without the 
addition of forskolin, an agent that stimulates adenylate 
cyclase. Following a basal efflux period in the absence of 
agonist, forskolin increased the 1251 efflux rate from PW- 
CFTR clone 6 from 0.32 to 0.70 min-l; PW 6 did not re- 
spond. r values obtained before forskolin addition and 
during the peak of the forskolin response provided an esti- 
mate of the relative stimulation of 1251 efflux (i.e., rforsk/ 
rbasal). In the responding PW-CFTR clones, the peak for- 
skolin effect on anion efflux was observed during the first 
three flux periods following forskolin addition (15-45 s). 
Isotopic anion (1251) effluxes were measured to screen the Data derived from 20 clones are illustrated in Figure 36. 
PW and PW-CFTR clones for CAMP- and Ca-stimulated Seven of ten PW-CFTR clones showed significant increases 
anion transport. The efflux assay provides a qualitative in 1251 efflux in response to forskolin, whereas none (O/10) 
estimate of agonist-stimulated Cl conductance pathways of the control PW clones responded to forskolin. The par- 
in Cl-secreting epithelia, as judged from the inhibitory ef- ent cell line, CFPAC-1, also shows no response to forskolin 
fects of Cl channel blockers and depolarizing membrane or CAMP analogs (Schoumacher et al., 1990). PW-CFTR 
potentials on 1251 efflux (Venglarik et al., 1990). Figure 3A clone 2 showed a major deletion in its CFTR cDNA by gel 
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Figure 3. Effect of Forskolin on lz51 Efflux in PW and PW-CFTR 
Clones 
(A) Time course of the efflux rate constant in clones 6. Forskolin (10 FM) 
was added at the indicated time. The first 60 s of efflux allows for 
washout of extracellular 1a5l and is not shown (see Experimental 
Procedures). Values are means f SEM of n = 9 determinations for 
each clone. 
(B) Ratio of forskolin-stimulated to basal ‘251 efflux in PW and PW- 
CFTR clones l-10. r values were taken before and after forskolin addi- 
tion. For PW-CFTR clone 2, the same scaling applies below 1.0. Values 
are means f SEM of n = 9 determinations for all clones except PW 
5, where n = 7. 
Cell 
1230 
blot hybridization (Figure 16) accounting for the failure of 
forskolin to stimulate lz51 efflux. In the seven responding 
PW-CFTR clones, the relative stimulation of anion efflux 
by forskolin ranged from 1.8 to 2.8-fold. This compares 
well with the 3.5-fold stimulation of efflux reported recently 
for the colonic tumor cell line T84 (Venglarik et al., 1990) 
and with the 2.9-fold stimulation by forskolin observed in 
primary cultures of normal human trachea (Li et al., 1988). 
The time course of stimulation in the PW-CFTR 8 clone 
is also similar to that observed in T84. Our  results indicate 
that expression of CFTR cDNA endows CFPAC-1 cells 
with CAMP-responsive anion efflux. 
The correlation between forskolin responsiveness of the 
PW-CFTR clones and their CFTR mRNA levels was not 
striking (compare Figures 2 and 38). Three of the best 
responders in the efflux assay showed high mRNA levels 
(i.e., PW-CFTR clones 1, 6, and 10). In other instances, 
however, the correlation was not as good. For example, 
clones 7 and 8 showed approximately a 2-fold response 
to forskolin but had relatively low mRNA levels, and clones 
3 and 9 showed a low forskolin response despite the pres- 
ence of readily detectable CFTR mRNA. 
Addition of the Ca ionophore ionomycin increased lz51 
efflux in all control and CFTR clones. Values of rrondrbasal 
averaged 14 + 2 in PLJ and 14 r 1 in PW-CFTR (n = 
20) in each group; no significant differences were de- 
tected between individual clones. The extent of response 
of PLJ clones to ionomycin is similar to that observed pre- 
viously in wild-type CFPAC-1 cells (Schoumacher et al., 
1990) and is about 3 times the response of T84 cells (Ven- 
glarik et al., 1990). The ability of Ca ionophores and Ca- 
mediated agonists to stimulate Cl secretion has been re- 
ported for airway and sweat gland cells derived from both 
normal individuals and CF patients (Sat0 and Sato, 1984; 
Frizzell et al., 1986; Willumsen and Boucher, 1989). The 
presence of this response in CF cells indicates that CFTR 
is not required for Ca-mediated stimulation of Cl transport. 
The lack of significant differences in the extent of Ca stim- 
ulation in PW and PW-CFTR clones suggests that CFTR 
does not modulate the activity of Ca-mediated regulatory 
pathways that govern Cl secretion. 
Clones Transduced with the CFTR Retrovirus 
Show cAMP-induced Cl Currents 
Whole-cell patch-clamp recordings were used to deter- 
mine whether the CAMP-induced increase in anion efflux 
in PW-CFTR clones (Figure 3) was due to stimulation of 
Cl conductance pathways (Cliff and Frizzell, 1990). A typi- 
cal response of PW-CFTR clone 1 is illustrated in Figure 
4A. Chloride currents were measured as the inward cur- 
rent produced by voltage pulses to -84 mV. Similar in- 
creases in inward current were observed in 11 of 13 cells 
from PW-CFTR clones 1, 6, and 10, in which addition of 
forskolin (5 PM) or CAMP (200-800 PM) increased inward 
currents from 220 k 68 pA to 1890 f 495 pA in respond- 
ing cells. The magnitude of this response compares favor- 
ably with that observed in T84 cells (Cliff and Frizzell, 
1990) and primary tracheal cell cultures derived from nor- 
mal subjects (W. H. C. and R. A. F., unpublished data). As 
shown in Figure 4B, no current responses were observed 
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Figure 4. Whole-Cell Cl Currents in PW and PW-CFTR Clones 
(A) Stimulation of inward currents in a PW-CFTR clone 1 cell by 5 nM 
forskolin under whole-cell voltage-clamp. Membrane voltage was held 
at -10 mV and pulsed to 0 and -64 mV The gap in the record 
represents time (6 min) during which bath solution substitutions were 
performed to determine ion selectivity of the forskolin-induced current 
(see [Cl). Pulse protocols for determining the I-V relations were run at 
the indicated times. Similar results were obtained in 11 PW-CFTR 
clone 1, 6, and 10 cells. 
(B) Failure of CAMP (400 PM) or forskolin (5 PM) to stimulate membrane 
currents in a PW clone 6 cell. Membrane voltage was held at -20 mV 
and pulsed to 0 mV and -64 mV. Similar results were obtained in six 
PW clone 6 cells. 
(C) lnstintaneous I-V relations of forskolin-induced currents in NaCl 
bath, low Cl bath, and Na-free bath. Forskolin-induced currents were 
obtained by digital subtraction of currents before and after stimulation; 
the values shown were recorded 6 ms after the initiation of voltage 
pulses. These data were obtained from the PW-CFTR clone 6 cell rec- 
ord shown in (A) during the 6 min recording gap. 
in cells from the control clone, PW 6 (n = 6). As observed 
for the lz51 efflux determinations, ionomycin (2 uM) in- 
creased inward currents in both PW (n = 4) and PLJ- 
CFTR (n = 3) clones. 
Figure 4C illustrates current-voltage (I-V) relations of 
the forskolin-stimulated current obtained from PW-CFTR 
clone 1. The I-V relation of the stimulated current ap- 
peared to be linear, as observed in T84 cells (Cliff and Friz- 
zell, 1990). Currents determined using equal bath and pi- 
pette Cl concentrations reversed near the Cl equilibrium 
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potential of 0 mV. Reducing the bath Cl concentration to 
6 mM (glutamate replacement) decreased the outward 
currents and shifted the reversal potential for current flow 
to +66 mV, a value close to the Cl equilibrium potential 
(+60 mV) for this outwardly directed Cl gradient. Replace- 
ment of bath Na by N-methyl-D-glucamine (NMDG) did not 
significantly alter the I-V relation. These findings indicate 
that the forskolin-stimulated current is Cl selective and 
that the stimulation of an anion efflux in PW-CFTR clones 
is due to activation of Cl conductance pathways. 
Discussion 
Our  findings indicate that expression of the normal CFTR 
gene from a retroviral vector confers CAMP-dependent Cl 
channel regulation on CF epithelial cells. CAMP and for- 
skolin increased anion efflux and Cl currents in CFTR- 
transduced CFPAC-1 clones but not in control clones. The 
time course and magnitude of stimulation in responding 
PW-CFTR clones are similar to those observed previously 
in normal human tracheal cells and T64 cells, which ex- 
press high levels of wild-type CFTR mRNA relative to 
other cell lines and tissues (Riordan et al., 1969). This sug- 
gests that CF cells are capable of transport responses 
that are physiologically significant in magnitude, provided 
that the normal gene can be expressed at reasonably high 
levels. 
Evidence that CFTR is in fact the gene for CF was, until 
now, based solely on genetic data. Numerous CFTR mu- 
tations have been identified that are found only on CF 
chromosomes. Most notable is the common AFm,, dele- 
tion, which has now been found on more than 9000 CF 
chromosomes (Cystic Fibrosis Genetic Analysis Consor- 
tium, 1990). Haplotype analyses suggest that the chromo- 
somes carrying AFr,oB may have descended from a com- 
mon ancestor (Kerem et al., 1969). It could be formally 
argued that this particular mutation was present on the 
ancestral CF chromosome and is a private polymorphism 
closely linked to the true CF mutation. This hypothesis 
would seem unlikely, however, based on the absence of 
AF5~ on other normal chromosomes of the same haplo- 
type, and the large number of additional mutations (in- 
cluding nonsense and frameshift abnormalities) subse- 
quently identified in CF chromosomes (Cutting et al., 
1990; White et al., 1990; Kerem et al., 1990; Dean et al., 
1990). The functional data presented here formally prove 
that CFTR is the CF gene; the addition of a single normal 
copy of CFTR to a CF cell alleviates the defect in Cl chan- 
nel regulation, as would be expected for a recessive trait 
such as CF. Furthermore, the complementation scheme 
described here provides an assay to determine the validity 
of other putative CF mutations and to study the function 
of CFTR by site-specific mutagenesis or domain switching 
with other members of this large ABC gene family (Hyde 
et al., 1990). 
Preliminary evidence has suggested the possibility of 
alternative splicing of several exons in CFTR mRNA Cr. 
Strong and F. S. C., unpublished data). Alternative tran- 
scriptional start sites have also been detected that could 
result in different amino termini (J. Koh and F. S. C., un- 
published data; J. M. R. and L.-C. T., unpublished data). 
The possibility that a combination of several CFTR protein 
isoforms might be necessary for normal Cl channel regu- 
lation has thus been raised. The success of the experi- 
ments described in this report demonstrates that the cDNA 
utilized here has all the sequences necessary to encode 
a functional protein, at least as assayed in CFPAC-1 cells 
by the analysis of CAMP-stimulated Cl current. Whether 
other forms of CFTR are also capable of complementa- 
tion, and whether all aspects of the CF phenotype can be 
complemented by the cDNA used here, remains to be de- 
termined. 
Results from both physiologic and molecular cloning 
studies have raised the possibility that CFTR is a Cl chan- 
nel. The defect in Cl channel activation by CAMP-depen- 
dent protein kinase is present at the single-channel level 
in cell-free membrane patches (Schoumacher et al., 1967; 
Li et al., 1966) and the protein structure predicted from CF 
gene cloning suggests that CFTR is an integral mem- 
brane protein with 12 membrane-spanning domains (Rior- 
dan et al., 1969). However,  in our study there is not a good 
correlation between the CAMP responsiveness of PW- 
CFTR clones and their CFfR mRNA levels. If the extent 
of CFTR expression corresponds to its mRNA levels, the 
lack of correlation between expression and transport sug- 
gests that a cellular component(s) other than CFTR is 
required for CAMP-stimulated anion transport. That is, 
CFTR is necessary but not sufficient for the Cl channel re- 
sponse, suggesting that CFTR is probably not a CAMP- 
dependent protein kinase-activatable Cl channel. We can- 
not exclude the possibility that clonal variabilities in other 
limiting factors account for this lack of correlation. 
CF-associated alterations in other cellular processes 
such as amiloride-sensitive Na transport (Boucher et al., 
1966) and mucin sulfation (Cheng et al., 1969) have been 
identified. This has given rise to the concept that CFTR 
may regulate several cellular processes. The role that 
CFTR plays in Cl channel regulation and in controlling 
other cellular events has not been elucidated, but the 
clonal PW cell lines will be useful for detailed studies of 
CFTR function. 
Our  results also suggest a strategy for treating CF 
based on retrovirus-mediated transfer of a normal CFTR 
gene into CF epithelial cells. We have shown that trans- 
duction of a single copy of the recombinant CFTR gene 
leads to stable correction of the Cl channel defect in pan- 
creatic cells and that retroviral vectors are a useful means 
of transfer despite the large size of the CFTR cDNA. Air- 
way epithelial cells, however, would be the most desirable 
targets for gene transfer because the pulmonary compli- 
cations of CF are usually its most morbid and life limiting 
(Taussig, 1964). Airway epithelial cells are easily infected 
with recombinant retroviruses (M. C. lannuzzi, M. L. D., 
and J. M. W., unpublished data), suggesting that the ap- 
proach described in this report may also be useful for 
gene therapies directed to the lung. 
Despite the encouraging data on functional comple- 
mentation of CF presented in this study, many major ques- 
tions remain about the feasibility of gene therapy of CF 
using a retrovirus. For example, what type of airway cell 
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is the appropriate target for gene transfer, and what are 
the consequences of ectopic expression or overexpres- 
sion of CFTR? Is it possible to achieve a therapeutic effect 
if the efficiency of gene transfer is less than 1000/o? What 
is the best strategy for obtaining stable and efficient recon- 
stitution of function in the airway in vivo without exposing 
the patient to excessive risks? The answers to these and 
other pressing questions in CF biology will need to be in- 
tensively sought in order to translate this retroviral com- 
plementation strategy into clinical practice. 
Experimental Procedures 
Cell Lines 
CFPAC-1 cells were maintained in culture as described previously 
(Schoumacher et al., 1990); cells used for retroviral infection were at 
passage 72. Infected populations of CFPAC-1 cells were selected in 
medium containing G418 (1 mglml) in order lo isolate individual clones. 
Transduced CFPAC-1 cells were removed from selection soon after 
they were expanded as clones. This was not associated with an appar- 
ent loss of proviral sequences or proviral expression. The amphotropic 
packaging cell line VCrip was maintained in Dulbecco’s modified Ea- 
gle’s medium supplemented with 10% calf serum and penicilli&.trep 
tomycin as described (Danos and Mulligan, 1988). 
Constructlon of CFTR cDNA 
The cDNA was constructed by joining the overlapping clones 10-1, 
T18-1, and T16-4.5 (Riordan et al., 1989). Clones IO-1 and T16-1 were 
ligated at the unique Nrul site in exon 4, and the resultant construct, 
spanning exons 1 through 13, was joined to T18-4.5. This was done by 
inserting a Sacl-EcoRI partial digestion product of T16-4.5, extending 
from exon 13 to exon 24, into the respective sites of the 5’ 13.exon con- 
struct. These manipulations generated a 4.5 kb clone containing the 
entire coding sequence as described (Riordan et al., 1989). It was ob- 
served that most clones generated from these construction attempts 
were grossly rearranged. Upon sequencing of an apparently intact 
construct, a 57 bp deletion was identified in exon 6b occurring between 
the two copies of a 13 bp direct repeat. On inspection, this interval was 
noted to contain a consensus prokaryotic promoter sequence. In an at- 
tempt to disrupt the repeat, three single-nucleotide alterations were 
made by in vitro mutagenesis (J. M. R. and L.-C. T., unpublished data). 
The introduced changes, which do not alter the CFTR translation prod- 
uct but result in a stable construct, include substitution of T for C at 
position 930, A for G at 933, and T for C at position 936. The modified 
reconstructed CFTR plasmid is called CFTR4.8 
Retrovlral Vectors and Recombinant Retrovlruaes 
Digestion of the modified CFTR plasmid with Sacl released the modi- 
fied CFTR cDNA on a 4.6 kb restriction fragment. The Sacl sites were 
converted to Bell sites with oligonucleotides, and the linkered fragment 
was cloned into the BarnHI site of the previously described retroviral 
vector PW (Korman et al., 1987). This recombinant vector, called PLJ- 
CFTR, is presented in Figure 1A. Retroviral vectors PLJ and PLJ-CFTR 
were transfected into the amphotropic packaging cell line @rip as de- 
scribed. Tissue culture medium was removed from plates containing 
the transfected packaging cells 24 hr later in order to harvest the tran- 
siently produced amphotropic virus. 
CFPAC-1 cells, passaged I:5 onto 10 cm2 plates, were exposed to 
viral supernatants supplemented with Polybrene (4 pglml) for 12 to 16 
hr. When the cells reached confluence, they were passaged 1:lO into 
medium containing G418 (1 mglml). Clones of cells were isolated, ex- 
panded, and cryopreserved. 
DNA and RNA Analysis of CFPAG1 Clones 
High molecular weight DNA was isolated from CFPAC-1 cells as de- 
scribed and analyzed by gel blot hybridization (Wilson et al., 1988). To- 
tal cellular RNA was purified and subjected to RNA blot analysis (Wil- 
son et al., 1988). Filters were hybridized with a variety of DNA probes 
that were labeled to a high specific activity using the random priming 
method (Feinberg and Vogelstein, 1983). These probes include the fol- 
lowing: exon 13 of CFTR. isolated following PCR amplification of 
cloned cDNA using oligonucleotides that flank the borders of this ex- 
on (nucleotides 1900 to 2811); Neo-specific sequences on a 960 bp 
Hindlll-Ncol fragment of pSV2Neo; and human y-acdn cDNA. 
Anion Efflux Measurements 
Radioisotopic anion efflux was determined as described (Venglarik et 
al., 1990). Briefly, cell monolayers were preloaded with lz51 for 30 min; 
after two washes, efflux was monitored at 15 s intervals using a sam- 
ple-replace procedure. At the end of the experiment, tracer remaining 
in the cell monolayer was extracted with 0.1 N NPOB. The efflux rate 
constant (r) for each sampling interval was calculated as follows: r = 
[ln(R,) - In(R#(t, - t2), where RI and R2 are the percent of loaded 
‘251 remaining in the monolayer at times 1, and 1*. Forskolin or ionomy- 
tin was added after the fifth 15 s sampling interval. The degree of 
agonist stimulation is expressed as ragonlst/rbasal, where ragon,* is the 
maximal value observed in the presence of agonist and rbw is taken 
from the flux interval immediately prior to agonist addition. 
Most of the extracellular 125l washout occurs during the initial 60 s 
of sampling (Venglarik et al., 1990); this period was ignored in the rate 
constant calculations. However, a small residual efflux from the ex- 
tracellular space after 80 s leads to a slight underestimate of the 
agonist response because the extracellular compartment washes out 
faster than the cellular compartment. Therefore, when there is no ef- 
flux response lo forskolin, r determined immediately after forskolin ad- 
dition is slightly less than that measured before forskolin is added. This 
accounts for the finding that r torsk/rbasa, is between 0.9 and 1.0 in the 
PLJ clones (Figure 38). 
Whole-Cell Current Recordings 
Macroscopic currents were recorded during whole-cell patch-clamp by 
methods previously described (Cliff and Frizzell, 1990). Recordings 
were made at 37% with the following solutions (mM): bath 115 NaCI, 
40 NMDG-glutamate, 5 potassium glutamate, 2 MgCI2, 1 CaCI,, 10 
HEPES (pH 7.2); pipette 115 KCI, 35 NMDG-glutamate, 0.25 EGTA. 
0.09 CaC12 (100 nM free Ca). 2 MgC12, 2 Na*ATP, 0.20 Na2GTP, 10 
HEPES (pH 7.2). Membrane potentials were clamped alternately for 
500 ms durations at three voltages, two of which were chosen to equal 
the equilibrium potentials for Cl (0 mV) and K (-84 mV). This permits 
the Cl and K currents to be monitored during agonist responses (Cliff 
and Frizzell, 1990). Pulsing was interrupted to determine I-V relations 
by stepping the clamp voltage between +-lo0 mV at 20 mV increments 
(Figure 4C). 
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